CardiAMP cell therapy (BioCardia)

N/A

Report date: 2023/07/10 11:04:01

Base Information

Drug NameCardiAMP cell therapy (BioCardia)
Drug Alias NameBone marrow cell therapyCardiac cell therapyCardiAMPBCDA-01BCDA-02
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Leukocyte cell therapy > Monocyte cell therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHeart Failure, SystolicHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesJapan
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesBiocardia Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiocardia Inc
Inactive CompaniesN/A
Active IndicationsHeart Failure, SystolicHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A